Trends and variation in the management of oesophagogastric cancer patients: A population-based survey

BMC Health Services Research

Volumn 9, Issue , 2009, Pages

  Lyratzopoulos, Georgios ^a   Barbiere, Josephine M ^a   Gajperia, Chetna ^a   Rhodes, Michael ^b   Greenberg, David C ^c   Wright, Karen A ^c  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b NORFOLK AND NORWICH UNIVERSITY HOSPITAL   (United Kingdom)

^c Eastern Cancer Registration and Information Centre   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AGED; ANALYSIS OF VARIANCE; ARTICLE; DISEASE MANAGEMENT; ESOPHAGUS TUMOR; FEMALE; GENERAL ASPECTS OF DISEASE; HUMAN; MALE; MIDDLE AGED;

ADULT; AGED; ANALYSIS OF VARIANCE; ANTINEOPLASTIC AGENTS; DISEASE; DISEASE MANAGEMENT; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; MALE; MIDDLE AGED;

EID: 75949084513     PISSN: None     EISSN: 14726963     Source Type: Journal    
DOI: 10.1186/1472-6963-9-231     Document Type: Article

References (33)

1. Report: Cancer incidence and mortality in the United Kingdom and constituent countries, 2003-05. S Westlake, Office for National Statistics. Health Statistics Quarterly 2008 40 91 7 http://www.statistics.gov.uk/downloads/ theme-health/HSQ40CancerUK2003-05.pdf (accessed December 2009)
2. An audit of the care received by people with Oesophago-Gastric Cancer in England and Wales. National Oesophago-Gastric Cancer Audit, First Annual Report 2008. The Information Centre. NHS http://www.ic.nhs.uk/webfiles/Services/NCASP/ Cancer/New%20web%20documents%20(OG)/28010208-NHSIC-OGAuditReport-FV-HR.pdf (accessed December 2009)
3. Surgical resection with or without preoperative chemotherapy in oesophageal cancer: randomised controlled trial. Medical Research Council Oesophageal Cancer Working Group, Lancet 2002 359 9319 1727 33 10.1016/S0140-6736(02)08651-8 12049861
4. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. D Cunningham WH Allum SP Stenning JN Thompson CJ Van de Velde M Nicolson JH Scarffe FJ Lofts SJ Falk TJ Iveson DB Smith RE Langley M Verma S Weeden YJ Chua MAGIC Trial Participants, N Engl J Med 2006 355 1 11 20 10.1056/NEJMoa055531 16822992
5. Influence of socio-economic deprivation on outcomes for patients diagnosed with gastric cancer. MR Stephens GR Blackshaw WG Lewis P Edwards JD Barry NA Hopper MC Allison, Scand J Gastroenterol 2005 40 1351 7 10.1080/00365520510023666 16334445
6. Population-based cancer survival trends in England and Wales up to 2007: an assessment of the NHS cancer plan for England. B Rachet C Maringe U Nur M Quaresma A Shah LM Woods L Ellis S Walters D Forman J Steward MP Coleman, Lancet Oncol 2009 10 351 69 10.1016/S1470-2045(09)70028-2 19303813
7. Survival from cancer of the stomach in England and Wales up to 2001. E Mitry B Rachet MJ Quinn N Cooper MP Coleman, Br J Cancer 2008 99 Suppl 1 16 8 10.1038/sj.bjc.6604574 18813246
8. Survival from cancer of the oesophagus in England and Wales up to 2001. E Mitry B Rachet MJ Quinn N Cooper MP Coleman, Br J Cancer 2008 99 Suppl 1 11 3 10.1038/sj.bjc.6604572 18813240
9. Trends in oesophageal and gastric cancer incidence, mortality and survival in England and Wales 1971-1998/1999. A Newnham MJ Quinn P Babb JY Kang A Majeed, Aliment Pharmacol Ther 2003 17 5 655 64 10.1046/j.1365-2036.2003. 01520.x 12641514 (Pubitemid 36418889)
10. Demographic and lifestyle predictors of survival in patients with esophageal or gastric cancers. KF Trivers AJ De Roos MD Gammon TL Vaughan HA Risch AF Olshan JB Schoenberg ST Mayne R Dubrow JL Stanford P Abrahamson H Rotterdam AB West JF Fraumeni WH Chow, Clin Gastroenterol Hepatol 2005 3 3 225 30 10.1016/S1542-3565(04)00613-5 15765441
11. Socioeconomic variation in colon cancer tumour factors associated with poorer prognosis. G Lyratzopoulos CR West EM Williams, Br J Cancer 2003 89 5 828 30 10.1038/sj.bjc.6601192 12942112
12. Absence of socioeconomic variation in survival from colorectal cancer in patients receiving surgical treatment in one health district: cohort study. G Lyratzopoulos GF Sheridan HR Michie P McElduff JH Hobbiss, Colorectal Dis 2004 6 6 512 7 10.1111/j.1463-1318.2004.00717.x 15521945
13. Origins of socio-economic inequalities in cancer survival: a review. LM Woods B Rachet MP Coleman, Ann Oncol 2006 17 1 5 19 10.1093/annonc/mdj007 16143594 (Pubitemid 43033834)
14. Relation between socioeconomic status and tumour stage in patients with breast, colorectal, ovarian, and lung cancer: results from four national, population based studies. DH Brewster CS Thomson DJ Hole RJ Black PL Stroner CR Gillis, BMJ 2001 322 830 1 10.1136/bmj.322.7290.830 11290637
15. Socioeconomic Inequalities in Cancer Survival in New Zealand:The Role of Extent of Disease at Diagnosis. M Jeffreys D Sarfati V Stevanovic M Tobias C Lewis N Pearce T Blakely, Cancer Epidemiol Biomarkers Prev 2009 18 915 21 10.1158/1055-9965.EPI-08-0685 19223561
16. An alternative approach to quantifying and addressing inequity in healthcare provision: access to surgery for lung cancer in the east of England. J Battersby J Flowers I Harvey, J Epidemiol Community Health 2004 58 7 623 5 10.1136/jech.2003.013391 15194729
17. No socioeconomic inequalities in colorectal cancer survival within a randomised clinical trial. U Nur B Rachet MK Parmar MR Sydes N Cooper C Lepage JM Northover R James MP Coleman AXIS collaborators, Br J Cancer 2008 2;99 11 1923 8 10.1038/sj.bjc.6604743
18. Influence of socio-economic deprivation on outcomes for patients diagnosed with oesophageal cancer. MA Morgan WG Lewis DS Chan S Burrows MR Stephens SA Roberts TJ Havard GW Clark TD Crosby, Scand J Gastroenterol 2007 42 10 1230 7 10.1080/00365520701320471 17852847
19. The NHS Cancer plan:a plan for investment, a plan for reform. Department of Health, http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/ PublicationsPolicyAndGuidance/DH-4009609 (accessed December 2009)
20. Cancer Reform Strategy. Department of Health, http://www.dh.gov.uk/en/ Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH-081006 (accessed December 2009)
21. UKACR Quality and Performance Indicators 2007: Final. Table 6. http://82.110.76.19/quality/UKACR%20report2009-final.xls (accessed December 2009)
22. Trends in incidence of adenocarcinoma of the oesophagus and gastric cardia in ten European countries. AA Botterweck LJ Schouten A Volovics E Dorant PA van Den Brandt, Int J Epidemiol 2000 29 4 645 54 10.1093/ije/29.4.645 10922340
23. Recent incidence trends and socio-demographic features of oesophageal and gastric cancer types in an English region. C Gajperia J Barbiere D Greenberg K Wright G Lyratzopoulos, Aliment Pharmacol Ther 2009 30 8 873 80 10.1111/j.1365-2036.2009.04100.x 19624549
24. Indices of Deprivation 2007. Communities and Local Government, http://www.communities.gov.uk/communities/neighbourhoodrenewal/deprivation/ deprivation07/ (accessed December 2009)
25. Choice of geographic unit influences socioeconomic inequalities in breast cancer survival. LM Woods B Rachet MP Coleman, Br J Cancer 2005 92 7 1279 82 10.1038/sj.bjc.6602506 15798765
26. OPCS-4 Intervention Classification. NHS Connecting for Health, http://www.connectingforhealth.nhs.uk/systemsandservices/data/clinicalcoding/ codingstandards/opcs4 (accessed December 2009)
27. International Union Against Cancer (UICC) TNM classification of malignant tumors. LH Sobin Ch Wittekind editors, New York: John Wiley & Sons, Inc 5 1997
28. Association of insurance status and ethnicity with cancer stage at diagnosis for 12 cancer sites:a retrospective analysis. MT Halpern EM Ward AL Pavluck NM Schrag J Bian AY Chen, Lancet Oncol 2008 9 3 222 31 10.1016/S1470-2045(08)70032-9 18282806
29. Impact of socioeconomic status on cancer incidence and stage at diagnosis: selected findings from the surveillance, epidemiology, and end results: National Longitudinal Mortality Study. LX Clegg ME Reichman BA Miller BF Hankey GK Singh YD Lin MT Goodman CF Lynch SM Schwartz VW Chen L Bernstein SL Gomez JJ Graff CC Lin NJ Johnson BK Edwards, Cancer Causes Control 2008 20 417 35 10.1007/s10552-008-9256-0 19002764
30. Comparison of comorbidity prevalence in oesophageal and gastric carcinoma patients: a population-based study. LB Koppert ML Janssen-Heijnen MW Louwman VE Lemmens BP Wijnhoven HW Tilanus JW Coebergh, Eur J Gastroenterol Hepatol 2004 16 7 681 8 10.1097/01.meg.0000108331.52416.f1 15201582
31. Risk factor measurement quality in primary care routine data was variable but nondifferential between individuals. G Lyratzopoulos RF Heller M Hanily PS Lewis, J Clin Epidemiol 2008 61 261 267 10.1016/j.jclinepi.2007.05.020 18226749
32. Patterns of care and effects on mortality for cancers of the oesophagus and gastric cardia: a population-based study. DP Cronin-Fenton L Sharp AE Carsin H Comber, Eur J Cancer 2007 43 3 565 75 10.1016/j.ejca.2006.10.011 17140789
33. The role of socio-economic status in the decision making on diagnosis and treatment of oesophageal cancer in The Netherlands. EP van Vliet MJ Eijkemans EW Steyerberg EJ Kuipers HW Tilanus A van der Gaast PD Siersema, Br J Cancer 2006 95 9 1180 5 10.1038/sj.bjc.6603374 17031405